Herbs could be the cure to ovarian cancer!When it comes to treating this disorder, existing drugs are often limited in ...

First-in-human trial of candidate from the next-generation ATTC platform —— Simultaneous China and global clinical development strategy to ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer ...

CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...

DNA sequencing technology makes it possible to explore the genome to learn how humans adapted to live in a wide range of ...

The researchers also examined how the compounds affected cell signalling pathways. They found evidence that CBD and THC ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...

New research taking place at the University of Plymouth's Brain Tumour Research Centre of Excellence, and supported by the ...